TH162735A - The use of PACAP to treat viral infections in aquatic organisms. - Google Patents

Abstract

DC60 (31/07/56) This invention involves the use of pituitary adenylate cyclase activating polypeptide. (PACAP) in the treatment of viral and infectious diseases caused by viruses in PACAP aquatic organisms, alone or when combined with antiviral molecules. Show its effectiveness by increasing the survival of fish or aquatic life. A hard shell that is infected with the virus when it is given by mouth By injection or by soaking tub It is also cheap. It was observed that the treated or treated organisms increased their weight compared to the infected and untreated organisms. PACAP or PACAP-containing aggregates decreased the number of viruses in the tissues and organs. Sensitive to Infected with the virus as it was determined by RT-PCR, the invention involved the use of pituitary adenylate cyclase activating polypeptide. (PACAP) in the treatment of viral and infectious diseases caused by viruses in PACAP aquatic organisms or when combined with viral molecules. Show its effectiveness by increasing the survival of fish or aquatic life. The infected crust remains when it is given by mouth. By injection or By injection tub or by soaking tub It is also cheap. It was observed that the treated or treated organisms increased their weight compared to the infected and untreated organisms. PACAP or PACAP-containing aggregates decreased the number of viruses in the tissues and organs. Sensitive to Virus infection as it is defined by RT-PCR patent medicine.

Claims (1)

: DC60 (31/07/56) This invention involves the use of pituitary adenylate cyclase activating polypeptide. (PACAP) in the treatment of viral and infectious diseases caused by viruses in PACAP aquatic organisms, alone or when combined with antiviral molecules. Show its effectiveness by increasing the survival of fish or aquatic life. A hard shell that is infected with the virus when it is given by mouth By injection or by soaking tub It is also cheap. It was observed that the treated or treated organisms increased their weight compared to the infected and untreated organisms. PACAP or PACAP-containing aggregates decreased the number of viruses in the tissues and organs. Sensitive to Infected with the virus as it was determined by RT-PCR, the invention involved the use of pituitary adenylate cyclase activating polypeptide. (PACAP) in the treatment of viral and infectious diseases caused by viruses in PACAP aquatic organisms or when combined with viral molecules. Show its effectiveness by increasing the survival of fish or aquatic life. The infected crust remains when it is given by mouth. By injection or By injection tub or by soaking tub It is also cheap. It was observed that the treated or treated organisms increased their weight compared to the infected and untreated organisms. PACAP or PACAP-containing aggregates decreased the number of viruses in the tissues and organs. Sensitive to Be infected with the virus as defined by RT-PCR Claims (Section One) which will appear on the advertisement page: Amendment 18/09/2015 1 5. Aggregate of Claims 14 where PACAP and antiviral molecules are administered by mouth, by injection or by infusion bath 1 6. The aggregate of claim 10, where the antiviral molecule is a chemical compound that is Pharmacy approved for the treatment of viral, functional or fragmented analogue virus. Its action 1 7. The aggregate of claim 15 is unique, since it is used as a part. Of formulated foods where PACAP is at a concentration of 50-750 ug / kg of food and antiviral compounds.